• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗诱导性心肌病中心脏再同步治疗的疗效和安全性:系统评价。

Efficacy and safety of cardiac resynchronization therapy in chemotherapy-induced cardiomyopathy: A systematic review.

机构信息

Department of Cardiology, Mufti Mehmood Memorial Teaching Hospital, DI Khan, Pakistan.

Department of Dermatology, Benazir Bhutto Hospital, Rawalpindi, Pakistan.

出版信息

Ann Noninvasive Electrocardiol. 2023 Sep;28(5):e13070. doi: 10.1111/anec.13070. Epub 2023 Jul 12.

DOI:10.1111/anec.13070
PMID:37435629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10475884/
Abstract

OBJECTIVE

The aim of the study was to assess the efficacy of cardiac resynchronization therapy (CRT) in patients with chemotherapy-induced cardiomyopathy (CIC).

METHODS

With the increasing incidence of CIC, the association of CRT with improvement in clinical outcomes, echocardiographic parameters, and New York Heart Classification (NYHA) class was assessed through this qualitative systematic review.

RESULTS

The five studies included a total of 169 patients who underwent CRT after CIC, and of these, 61 (36.1%) patients were males. All studies showed an improvement in left ventricular ejection fraction (LVEF), among other echocardiographic parameters of LV volume. However, these findings are limited by short follow-up periods, small sample sizes, and the absence of a control group.

CONCLUSION

CRT was associated with improvement in all patient parameters with CIC.

摘要

目的

本研究旨在评估心脏再同步治疗(CRT)在化疗诱导性心肌病(CIC)患者中的疗效。

方法

随着 CIC 发病率的增加,通过定性系统评价评估了 CRT 与临床结局、超声心动图参数和纽约心功能分级(NYHA)的改善之间的关联。

结果

这 5 项研究共纳入了 169 例在 CIC 后接受 CRT 的患者,其中 61 例(36.1%)为男性。所有研究均显示左心室射血分数(LVEF)以及左心室容积等超声心动图参数得到改善。然而,这些发现受到随访时间短、样本量小以及缺乏对照组的限制。

结论

CRT 与 CIC 患者的所有参数改善相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67b/10475884/be501c65b19c/ANEC-28-e13070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67b/10475884/28ef512a0ef0/ANEC-28-e13070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67b/10475884/be501c65b19c/ANEC-28-e13070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67b/10475884/28ef512a0ef0/ANEC-28-e13070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67b/10475884/be501c65b19c/ANEC-28-e13070-g003.jpg

相似文献

1
Efficacy and safety of cardiac resynchronization therapy in chemotherapy-induced cardiomyopathy: A systematic review.化疗诱导性心肌病中心脏再同步治疗的疗效和安全性:系统评价。
Ann Noninvasive Electrocardiol. 2023 Sep;28(5):e13070. doi: 10.1111/anec.13070. Epub 2023 Jul 12.
2
The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.心脏再同步治疗后心力衰竭患者性别差异对临床和超声心动图结局的影响:一项系统评价和荟萃分析。
PLoS One. 2017 Apr 28;12(4):e0176248. doi: 10.1371/journal.pone.0176248. eCollection 2017.
3
Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.轻度心力衰竭患者的心脏再同步治疗:一项系统评价和荟萃分析。
J Interv Card Electrophysiol. 2011 Nov;32(2):125-35. doi: 10.1007/s10840-011-9584-y. Epub 2011 May 19.
4
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.通过负荷超声心动图评估左心室收缩储备作为心力衰竭患者心脏再同步治疗反应预测指标的系统评价和荟萃分析
BMC Cardiovasc Disord. 2017 Aug 16;17(1):223. doi: 10.1186/s12872-017-0657-4.
5
Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.心脏再同步治疗心力衰竭患者:系统评价和荟萃分析。
J Am Coll Cardiol. 2011 Aug 23;58(9):935-41. doi: 10.1016/j.jacc.2011.05.022.
6
Outcomes of Cardiac Resynchronization Therapy with Image-Guided Left Ventricular Lead Placement at the Site of Latest Mechanical Activation: A Systematic Review and Meta-Analysis.基于最新机械激活部位的影像引导左心室导线放置的心脏再同步治疗的结局:系统评价和荟萃分析。
J Interv Cardiol. 2022 May 20;2022:6285894. doi: 10.1155/2022/6285894. eCollection 2022.
7
Improved outcomes of conduction system pacing in heart failure with reduced ejection fraction: A systematic review and meta-analysis.心力衰竭伴射血分数降低患者心脏再同步起搏治疗预后改善的系统评价和荟萃分析
Heart Rhythm. 2023 Aug;20(8):1178-1187. doi: 10.1016/j.hrthm.2023.05.010. Epub 2023 May 10.
8
Multipoint pacing for cardiac resynchronisation therapy in patients with heart failure: A systematic review and meta-analysis.多点起搏用于心力衰竭患者心脏再同步治疗的系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2021 Sep;32(9):2577-2589. doi: 10.1111/jce.15199. Epub 2021 Aug 19.
9
Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: A systematic review.超声心动图与心内心电图指导心脏再同步治疗优化的比较:系统评价。
Ann Noninvasive Electrocardiol. 2023 Mar;28(2):e13040. doi: 10.1111/anec.13040. Epub 2023 Jan 6.
10
Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network meta-analysis.心脏再同步治疗中传导系统起搏的有效性:系统评价和网络荟萃分析。
J Cardiovasc Electrophysiol. 2023 Nov;34(11):2342-2359. doi: 10.1111/jce.16086. Epub 2023 Sep 28.

引用本文的文献

1
Cardiac resynchronization therapy in cancer patients with chemotherapy-induced cardiomyopathy: a mini review.癌症患者化疗所致心肌病的心脏再同步治疗:一篇综述
Heart Fail Rev. 2025 Sep 4. doi: 10.1007/s10741-025-10554-7.

本文引用的文献

1
Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: A systematic review.超声心动图与心内心电图指导心脏再同步治疗优化的比较:系统评价。
Ann Noninvasive Electrocardiol. 2023 Mar;28(2):e13040. doi: 10.1111/anec.13040. Epub 2023 Jan 6.
2
Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy.蒽环类药物所致心肌病的心脏再同步治疗
Heart. 2022 Feb;108(4):274-278. doi: 10.1136/heartjnl-2020-318333. Epub 2021 Sep 6.
3
Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathy.
化疗诱导性心肌病患者心脏再同步治疗的结局。
Pacing Clin Electrophysiol. 2021 Apr;44(4):625-632. doi: 10.1111/pace.14196. Epub 2021 Mar 15.
4
Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.心脏再同步治疗与化疗诱导性心肌病患者左心室射血分数变化的关系。
JAMA. 2019 Nov 12;322(18):1799-1805. doi: 10.1001/jama.2019.16658.
5
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.累积蒽环类药物暴露与心脏毒性风险;丹麦一项针对 2440 例接受或未接受蒽环类药物治疗的淋巴瘤患者的全国队列研究。
Br J Haematol. 2018 Dec;183(5):717-726. doi: 10.1111/bjh.15603. Epub 2018 Nov 8.
6
The Use of Cardiac Resynchronization Therapy in Cancer Patients with Heart Failure.心脏再同步治疗在癌症合并心力衰竭患者中的应用
J Clin Exp Res Cardiol. 2017 Apr;3(1). doi: 10.15744/2394-6504.3.105. Epub 2017 Apr 27.
7
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.辅助性乳腺癌治疗期间心脏功能障碍的预防(PRADA):一项关于坎地沙坦和美托洛尔的2×2析因、随机、安慰剂对照、双盲临床试验。
Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21.
8
Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.早期发现蒽环类药物心脏毒性并通过心力衰竭治疗得到改善。
Circulation. 2015 Jun 2;131(22):1981-8. doi: 10.1161/CIRCULATIONAHA.114.013777. Epub 2015 May 6.
9
Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy.阿霉素诱导性心肌病患者心脏再同步治疗的作用。
Am J Cardiol. 2010 Feb 15;105(4):522-6. doi: 10.1016/j.amjcard.2009.10.024.
10
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.